维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

15篇 您的检索式：作者名="Paulus JD"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	A randomized phase Ⅲ comparison of standard-dose ( 60 Gy ) versus high-dose ( 74 Gy ) conformal chemoradiotherapy with or without cetuximab for stage Ⅲ non-small cell lung cancer: results on radiation dose in RTOG 0617 显示文摘	Bradley JD Paulus R Komaki R	2013	J Clin Oncol2013，3115，：	1
	2	Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or with- out cetuximab for patients with stage Ilia or IIIB non- small-cell lung cancer ( RTOG 0617 ) : a randomised, two-by-two factorial phase 3 study 显示文摘	Bradley JD Paulus R Komaki R	2015	Lancet Oncol2015，16，2：	1
	3	Loss of optineurin in vivo results in elevated cell death and alters axonal trafficking dynamics显示文摘	Paulus JD Link BA	2014	PLoS One2014，9，10：	1
	4	Standard-dose versus high-dose confornml radiotherapy with concurrent and consolidation earboplatin plus paclitaxel with or without cetuximab for patients with stage m A or mB non-small-cell lung cancer( RTOG 0617 ) :a randomised, two-by- two factorial phase 3 study 显示文摘	Bradley JD Paulus R Komaki R	2015	Lancet Oncol2015，16，2：	1
	5	Phase Ⅱ trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage Ⅱ and Ⅲ A non-small-cell lung cancer: promising long-term re- sults of the Radiation Therapy Oncology Group-RTOG 9705 显示文摘	Bradley JD Paulus R Graham MV	2005	J Clin Onco12005，23，15：	1
	6	Standard-dose ver- sus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer( RTOG 0617 ) :a randomised, two-by-two facto- rim phase 3 study 显示文摘	Bradley JD Paulus R Komaki R	2015	Lancet Oncol2015，16，2：	1
	7	Phase Ⅱ trial of postoperative adjuvant paditaxel/earboplatin and thoracic radiotherapy in resected stage Ⅱ and Ⅲ non-small lung cancer:Promising long-rerm results of R TOG 9705 concurrent chemoradiotherapy in non-small cell lung cancer显示文摘	Bradley JD Paulus R Graham MV	2005	Database Sys Rev J Clin Oncol2005，23，15：	1
	8	Phase Ⅱ Trial of Postoperative Adjuvant Paclitaxel/Carboplatin and Thoracic Radiotherapy in Resected Stage Ⅱ and ⅢA Non-Small-Cell Lung Cancer: Promising Long-Term Results of the Radiation Therapy Oncology Group-RTOG9705 显示文摘	Bradley JD Paulus R Graham MV	2005	J Clin Oncol2005，23，15：	1
	9	Standard-dose ver- sus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage m A or III B non-small- cell lung cancer (RTOG 0617): a randomized,two-by-two factorial phase 3 study显示文摘	Bradley JD Paulus R Komaki R	2015	Lancet Oncol2015，16，：	1
	10	Standard-dose versus high-dose conformal radiotherapy with concurrent and consolida- tion carboplatin plus paclitaxel with or without cetuximab for pa- tients with stage In A or 显示文摘	Bradley JD Paulus R Komaki R	2015	Lancet Oncol2015，16，2：	1
	11	A randomized phase III comparison of standard-dose(60 Gy)versus high-dose(74 Gy)conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer:Results on radiation dose in RTOG 0617显示文摘	Bradley JD Paulus R Komaki R	2013	J Clin Oncol2013，31，15：	1
	12	Phase Ⅱ trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage Ⅱ and ⅢA non-small-cell lung cancer: promising longterm results of the Radiation Therapy Oncology Group-RTOG 9705 显示文摘	Bradley JD Paulus R Graham MV	2005	J Clin Oncol2005，23，15：	1
	13	Standard-dose versus high-dose eonformal radiotherapy with concurrent and consolida- tion earboplatin plus paelitaxel with or without eetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study显示文摘	Bradley JD R Paulus R Komaki	2015	Lancet Oncol2015，16，2：	1
	14	Standard-dose versus high- dose conforma] radiotherapy with concurrent and consolidation car- hoplatin plus pac显示文摘	Bradley JD Paulus R Komaki R	2015	Lancet Oncol2015，16，2：	1
	15	Standard-dose versus high- dose conformal radiotherapy with concurrent and consolidation car- boplatin plus paclitaxel with or without cetuximab for patients with stage mA or mB non-small-cell lung cancer (RTOG 0617):a ran- domised, two-by-two factorial phase 3 study显示文摘	Bradley JD Paulus R Komaki R	2015	Lancet Oncol2015，16，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费